Loading…

Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue

The presence of neck metastases represents one of the most important prognostic factors for carcinomas of the anterior tongue, the five-year survival rate being under 20% in patients with regional metastases. The aim of this study was to demonstrate the efficacy of prophylactic selective neck dissec...

Full description

Saved in:
Bibliographic Details
Published in:Hippokratia 2014-01, Vol.18 (2), p.120-124
Main Authors: Mirea, D, Grigore, R, Safta, D, Mirea, L, Popescu, Cr, Popescu, B, Berteşteanu, Svg
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 124
container_issue 2
container_start_page 120
container_title Hippokratia
container_volume 18
creator Mirea, D
Grigore, R
Safta, D
Mirea, L
Popescu, Cr
Popescu, B
Berteşteanu, Svg
description The presence of neck metastases represents one of the most important prognostic factors for carcinomas of the anterior tongue, the five-year survival rate being under 20% in patients with regional metastases. The aim of this study was to demonstrate the efficacy of prophylactic selective neck dissection in patients without detectable nodal metastases. A matched case-control study with prospective follow up was conducted in ENT Department of Coltea Clinical Hospital for 86 patients with T1-T2N0 stage carcinoma of the anterior tongue surgically treated between January 2000 and January 2005 with or without concurrent selective supraomohyoid neck dissection (SND). The patients were divided in two groups, comparable in age and sex distribution. Descriptive statistics, risk of recurrences, Kaplan Maier five-year survival curves and the global and specific mortality rates were performed using EpiInfo software. The level of significance was established at p
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4201396</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1615742296</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-2f4cba9d4288c2e5e9818295749ad87bf136536806c220a2cb9527e74b7a3c623</originalsourceid><addsrcrecordid>eNpVkE1PwzAMhisEYmPwF1COXColTpsmFyQ0xoc0jcuQuFVp5m6BNhlNOsS_p8BAcLItW8_7yAfJmBWKppIydTj0jMo0Y1KNkpMQnikVIAQ9TkaQcy5kwcfJ06xBE-0OyQLNC7m2IXzO3hHryFZHiy4G8mbjhoSo10iWLF3CghKjO2OdbzXxNYkbJNpF7KzvSPRu3eNpclTrJuDZvk6Sx5vZcnqXzh9u76dX83Q7uMQU6sxUWq0ykNIA5qgkk6DyIlN6JYuqZlzkgysVBoBqMJXKocAiqwrNjQA-SS6_udu-anFlBt9ON-W2s63u3kuvbfl_4-ymXPtdmQFlXIkBcLEHdP61xxDL1gaDTaMd-j6UTLDBBuDr9Pxv1m_Izzv5B9sgckU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1615742296</pqid></control><display><type>article</type><title>Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue</title><source>PubMed Central</source><creator>Mirea, D ; Grigore, R ; Safta, D ; Mirea, L ; Popescu, Cr ; Popescu, B ; Berteşteanu, Svg</creator><creatorcontrib>Mirea, D ; Grigore, R ; Safta, D ; Mirea, L ; Popescu, Cr ; Popescu, B ; Berteşteanu, Svg</creatorcontrib><description>The presence of neck metastases represents one of the most important prognostic factors for carcinomas of the anterior tongue, the five-year survival rate being under 20% in patients with regional metastases. The aim of this study was to demonstrate the efficacy of prophylactic selective neck dissection in patients without detectable nodal metastases. A matched case-control study with prospective follow up was conducted in ENT Department of Coltea Clinical Hospital for 86 patients with T1-T2N0 stage carcinoma of the anterior tongue surgically treated between January 2000 and January 2005 with or without concurrent selective supraomohyoid neck dissection (SND). The patients were divided in two groups, comparable in age and sex distribution. Descriptive statistics, risk of recurrences, Kaplan Maier five-year survival curves and the global and specific mortality rates were performed using EpiInfo software. The level of significance was established at p&lt;0.05. After a mean follow-up time of 90.5 months, for all variables considered as outcomes of SND efficacy evaluation, significance differences (p &lt; 0.05) were registered between groups: the frequency of patients who developed neck metastases was lower in the group of subjects who underwent prophylactic selective neck dissection; the all-cause mortality rate at the end of the follow-up period was three times lower in SND study group compared with controls; the specific mortality rate due to regional recurrences was five times lower in test-group compared with controls. Our study suggest that prophylactic selective neck dissection could be indicated for patients with T1-T2N0 carcinomas of the anterior tongue in order to increase both overall and free of recurrence survival time, respectivelly.</description><identifier>ISSN: 1108-4189</identifier><identifier>EISSN: 1790-8019</identifier><identifier>PMID: 25336873</identifier><language>eng</language><publisher>Greece: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</publisher><subject>Original</subject><ispartof>Hippokratia, 2014-01, Vol.18 (2), p.120-124</ispartof><rights>Copyright 2014, Hippokratio General Hospital of Thessaloniki 2014</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201396/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201396/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25336873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirea, D</creatorcontrib><creatorcontrib>Grigore, R</creatorcontrib><creatorcontrib>Safta, D</creatorcontrib><creatorcontrib>Mirea, L</creatorcontrib><creatorcontrib>Popescu, Cr</creatorcontrib><creatorcontrib>Popescu, B</creatorcontrib><creatorcontrib>Berteşteanu, Svg</creatorcontrib><title>Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue</title><title>Hippokratia</title><addtitle>Hippokratia</addtitle><description>The presence of neck metastases represents one of the most important prognostic factors for carcinomas of the anterior tongue, the five-year survival rate being under 20% in patients with regional metastases. The aim of this study was to demonstrate the efficacy of prophylactic selective neck dissection in patients without detectable nodal metastases. A matched case-control study with prospective follow up was conducted in ENT Department of Coltea Clinical Hospital for 86 patients with T1-T2N0 stage carcinoma of the anterior tongue surgically treated between January 2000 and January 2005 with or without concurrent selective supraomohyoid neck dissection (SND). The patients were divided in two groups, comparable in age and sex distribution. Descriptive statistics, risk of recurrences, Kaplan Maier five-year survival curves and the global and specific mortality rates were performed using EpiInfo software. The level of significance was established at p&lt;0.05. After a mean follow-up time of 90.5 months, for all variables considered as outcomes of SND efficacy evaluation, significance differences (p &lt; 0.05) were registered between groups: the frequency of patients who developed neck metastases was lower in the group of subjects who underwent prophylactic selective neck dissection; the all-cause mortality rate at the end of the follow-up period was three times lower in SND study group compared with controls; the specific mortality rate due to regional recurrences was five times lower in test-group compared with controls. Our study suggest that prophylactic selective neck dissection could be indicated for patients with T1-T2N0 carcinomas of the anterior tongue in order to increase both overall and free of recurrence survival time, respectivelly.</description><subject>Original</subject><issn>1108-4189</issn><issn>1790-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkE1PwzAMhisEYmPwF1COXColTpsmFyQ0xoc0jcuQuFVp5m6BNhlNOsS_p8BAcLItW8_7yAfJmBWKppIydTj0jMo0Y1KNkpMQnikVIAQ9TkaQcy5kwcfJ06xBE-0OyQLNC7m2IXzO3hHryFZHiy4G8mbjhoSo10iWLF3CghKjO2OdbzXxNYkbJNpF7KzvSPRu3eNpclTrJuDZvk6Sx5vZcnqXzh9u76dX83Q7uMQU6sxUWq0ykNIA5qgkk6DyIlN6JYuqZlzkgysVBoBqMJXKocAiqwrNjQA-SS6_udu-anFlBt9ON-W2s63u3kuvbfl_4-ymXPtdmQFlXIkBcLEHdP61xxDL1gaDTaMd-j6UTLDBBuDr9Pxv1m_Izzv5B9sgckU</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Mirea, D</creator><creator>Grigore, R</creator><creator>Safta, D</creator><creator>Mirea, L</creator><creator>Popescu, Cr</creator><creator>Popescu, B</creator><creator>Berteşteanu, Svg</creator><general>SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue</title><author>Mirea, D ; Grigore, R ; Safta, D ; Mirea, L ; Popescu, Cr ; Popescu, B ; Berteşteanu, Svg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-2f4cba9d4288c2e5e9818295749ad87bf136536806c220a2cb9527e74b7a3c623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Mirea, D</creatorcontrib><creatorcontrib>Grigore, R</creatorcontrib><creatorcontrib>Safta, D</creatorcontrib><creatorcontrib>Mirea, L</creatorcontrib><creatorcontrib>Popescu, Cr</creatorcontrib><creatorcontrib>Popescu, B</creatorcontrib><creatorcontrib>Berteşteanu, Svg</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hippokratia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirea, D</au><au>Grigore, R</au><au>Safta, D</au><au>Mirea, L</au><au>Popescu, Cr</au><au>Popescu, B</au><au>Berteşteanu, Svg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue</atitle><jtitle>Hippokratia</jtitle><addtitle>Hippokratia</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>18</volume><issue>2</issue><spage>120</spage><epage>124</epage><pages>120-124</pages><issn>1108-4189</issn><eissn>1790-8019</eissn><abstract>The presence of neck metastases represents one of the most important prognostic factors for carcinomas of the anterior tongue, the five-year survival rate being under 20% in patients with regional metastases. The aim of this study was to demonstrate the efficacy of prophylactic selective neck dissection in patients without detectable nodal metastases. A matched case-control study with prospective follow up was conducted in ENT Department of Coltea Clinical Hospital for 86 patients with T1-T2N0 stage carcinoma of the anterior tongue surgically treated between January 2000 and January 2005 with or without concurrent selective supraomohyoid neck dissection (SND). The patients were divided in two groups, comparable in age and sex distribution. Descriptive statistics, risk of recurrences, Kaplan Maier five-year survival curves and the global and specific mortality rates were performed using EpiInfo software. The level of significance was established at p&lt;0.05. After a mean follow-up time of 90.5 months, for all variables considered as outcomes of SND efficacy evaluation, significance differences (p &lt; 0.05) were registered between groups: the frequency of patients who developed neck metastases was lower in the group of subjects who underwent prophylactic selective neck dissection; the all-cause mortality rate at the end of the follow-up period was three times lower in SND study group compared with controls; the specific mortality rate due to regional recurrences was five times lower in test-group compared with controls. Our study suggest that prophylactic selective neck dissection could be indicated for patients with T1-T2N0 carcinomas of the anterior tongue in order to increase both overall and free of recurrence survival time, respectivelly.</abstract><cop>Greece</cop><pub>SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL"</pub><pmid>25336873</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1108-4189
ispartof Hippokratia, 2014-01, Vol.18 (2), p.120-124
issn 1108-4189
1790-8019
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4201396
source PubMed Central
subjects Original
title Elective Neck Dissection in patients with stage T1-T2N0 carcinoma of the anterior tongue
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T16%3A04%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elective%20Neck%20Dissection%20in%20patients%20with%20stage%20T1-T2N0%20carcinoma%20of%20the%20anterior%20tongue&rft.jtitle=Hippokratia&rft.au=Mirea,%20D&rft.date=2014-01-01&rft.volume=18&rft.issue=2&rft.spage=120&rft.epage=124&rft.pages=120-124&rft.issn=1108-4189&rft.eissn=1790-8019&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1615742296%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p266t-2f4cba9d4288c2e5e9818295749ad87bf136536806c220a2cb9527e74b7a3c623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1615742296&rft_id=info:pmid/25336873&rfr_iscdi=true